172 related articles for article (PubMed ID: 20723297)
1. [Reversal effect of nuclear factor-κB protease inhibitor PDTC on multidrug resistance of K562/AO₂ cells and its mechanism].
Yang TT; Xue TY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):903-8. PubMed ID: 20723297
[TBL] [Abstract][Full Text] [Related]
2. [NF-kappaB regulating expression of mdr1 gene and P-gp to reverse drug-resistance in leukemic cells].
Wang Y; Liu X; Zhang HT; Yu M; Wang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):950-4. PubMed ID: 17956668
[TBL] [Abstract][Full Text] [Related]
3. [NF-κ B mediates the effect of glucosylceramide synthase on P-glycoprotein modulation in a drug-resistance leukemia cell line].
Zhang X; Xie K; Zou J; Li Y; Mu H; Zhang B; Xie P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):34-8. PubMed ID: 24510559
[TBL] [Abstract][Full Text] [Related]
4. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma.
Morais C; Gobe G; Johnson DW; Healy H
Apoptosis; 2010 Apr; 15(4):412-25. PubMed ID: 19856104
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Bmi-1 on Multidrug Resistance in K562/ADR Cells and Its Mechanisms].
Zhao BX; Liu SQ; Dong SC; Jing RN; Meng XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):758-766. PubMed ID: 32552933
[TBL] [Abstract][Full Text] [Related]
7. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection in mesenchymal stem cells and their activation could be enhanced by nuclear factor-κB inhibitor pyrrolidinedithiocarbamate in vitro.
Wei G; Lin M; Cai Z; Huang H
Transplant Proc; 2011 Jun; 43(5):1944-9. PubMed ID: 21693305
[TBL] [Abstract][Full Text] [Related]
9. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma.
Liu J; Zhu M; Feng Y; Tang Q; Xu M
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400857
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of reversing multi-drug resistance of K562/AO2 by puerarin].
Chen JW; Tao S; Luo R; Zhang GS; Xu YX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):216-21. PubMed ID: 18382055
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of nuclear factor kappa B attenuates multiple organ injury following ruptured abdominal aortic aneurysm: an experiment with rats].
Yang J; Hu XH; Liu CW; Zhang ZS; Li TM; Yang DH; Zhang Q
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):237-41. PubMed ID: 16677502
[TBL] [Abstract][Full Text] [Related]
12. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
13. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
[TBL] [Abstract][Full Text] [Related]
14. MDR reversal activity of bromotetrandrine in vitro and in vivo.
Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
[TBL] [Abstract][Full Text] [Related]
15. [Effects of tetrandrine on nuclear factor-kappaB expression in leukemia multidrug-resistant cell line K562/A02].
Chen BA; Su AL; Cheng J; Zhao HH; Li GH; Wang XM
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):956-9. PubMed ID: 18782542
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB activation has tissue-specific effects on immune cell apoptosis during polymicrobial sepsis.
Joshi AR; Chung CS; Song GY; Lomas J; Priester RA; Ayala A
Shock; 2002 Oct; 18(4):380-6. PubMed ID: 12392284
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
18. [Orphanin FQ combined with adriamycin reverses multi-drug resistance of K562/ADM and its molecular mechanism].
Wang XX; Liu XQ; Zhang W; Chen X; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):574-8. PubMed ID: 22739158
[TBL] [Abstract][Full Text] [Related]
19. Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells.
Zhang HM; Sang XG; Wang YZ; Cui C; Zhang L; Ji WS
World J Gastroenterol; 2017 Apr; 23(15):2716-2722. PubMed ID: 28487608
[TBL] [Abstract][Full Text] [Related]
20. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance.
Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P
Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
